Browsing Tag
CRISPR
6 posts
FDA clears GenEditBio to begin human testing of GEB-101, a first-in-class genome-editing therapy for TGFBI corneal dystrophy
Find out how GenEditBio's GEB-101 genome-editing therapy just cleared FDA to begin trials for TGFBI corneal dystrophy. Could it redefine in vivo editing?
Caribou Biosciences set for key webcast showcasing CRISPR-engineered CAR-T breakthroughs in blood cancers
Discover how Caribou Biosciences is preparing to reveal breakthrough CRISPR-edited allogeneic CAR-T data in lymphoma and myeloma during its investor webcast.
Intellia’s Nexiguran Ziclumeran (nex-z) phase 3 trials paused following grade 4 liver toxicity event
Find out why Intellia Therapeutics paused its phase 3 Nexiguran Ziclumeran (nex-z) trials after a severe liver event—and what it means for CRISPR’s future.
Be Biopharma reports positive preclinical data for BE-102 in hypophosphatasia
Be Biopharma shares preclinical results for BE-102, a B cell medicine in development for treating hypophosphatasia. Read about its novel approach.
Illumina teams up with Broad Clinical Labs to drive drug discovery collaboration
Illumina, Inc., a global leader in genomic sequencing technology, has announced a strategic collaboration with Broad Clinical Labs…
Caribou Biosciences launches CB-010 GALLOP Phase 1 trial in lupus
Caribou Biosciences, Inc., a clinical-stage leader in CRISPR genome-editing biopharmaceuticals, has announced the initiation of its CB-010 GALLOP…